3HC5 | Transcription | date | May 05, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Fxr With Src1 And Gsk826 | ||||||||||||||
authors | S.P.Williams, K.P.Madauss | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Bile Acid Receptor Chain: A Fragment: Fxr Synonym: Farnesoid X-Activated Receptor, Farnesol Receptor Nuclear Receptor Subfamily 1 Group H Member 4, Retinoid X R Interacting Protein 14, Rxr-Interacting Protein 14; Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Bar, Fxr, Hrr1, Nr1h4, Rip14 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Prseta | ||||||||||||||
Molecule: Nuclear Receptor Coactivator 1 Chain: B Fragment: Src1 Engineered: Yes |
Synthetic: Yes | ||||||||||||||
symmetry | Space Group: F 2 3 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 Å | ||||||||||||
ligand | 82X, SO4 BindingDB | enzyme |
| ||||||||||||
Primary reference | FXR agonist activity of conformationally constrained analogs of GW 4064., Akwabi-Ameyaw A, Bass JY, Caldwell RD, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, Marr HB, McFadyen RB, Miller AB, Navas F 3rd, Parks DJ, Spearing PK, Todd D, Williams SP, Bruce Wisely G, Bioorg Med Chem Lett. 2009 Jun 21. PMID:19586769 |
Data retrieval |
View 3HC5 in 3D |
Visual 3D analysis of 3HC5 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3HC5 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |